Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016:2016:7962502.
doi: 10.1155/2016/7962502. Epub 2016 Jan 10.

What Prevents Men Aged 40-64 Years from Prostate Cancer Screening in Namibia?

Affiliations

What Prevents Men Aged 40-64 Years from Prostate Cancer Screening in Namibia?

Joseph Kangmennaang et al. J Cancer Epidemiol. 2016.

Abstract

Objectives. Although a growing body of evidence demonstrates the public health burden of prostate cancer in SSA, relatively little is known about the underlying factors surrounding the low levels of testing for the disease in the context of this region. Using Namibia Demographic Health Survey dataset (NDHS, 2013), we examined the factors that influence men's decision to screen for prostate cancer in Namibia. Methods. We use complementary log-log regression models to explore the determinants of screening for prostate cancer. We also corrected for the effect of unobserved heterogeneity that may affect screening behaviours at the cluster level. Results. The results show that health insurance coverage (OR = 2.95, p = 0.01) is an important predictor of screening for prostate cancer in Namibia. In addition, higher education and discussing reproductive issues with a health worker (OR = 2.02, p = 0.05) were more likely to screening for prostate cancer. Conclusions. A universal health insurance scheme may be necessary to increase uptake of prostate cancer screening. However it needs to be acknowledged that expanded screening can have negative consequences and any allocation of scarce resources towards screening must be guided by evidence obtained from the local context about the costs and benefits of screening.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Torre L. A., Bray F., Siegel R. L., Ferlay J., Lortet-Tieulent J., Jemal A. Global cancer statistics, 2012. CA—A Cancer Journal for Clinicians. 2015;65(2):87–108. doi: 10.3322/caac.21262. - DOI - PubMed
    1. GLOBOCAN. GLOBOCAN 2012: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2012. GLOBOCAN; 2015. http://globocan.iarc.fr/Pages/fact_sheets_population.aspx.
    1. Rebbeck T. R., Devesa S. S., Chang B.-L., et al. Global patterns of prostate cancer incidence, aggressiveness, and mortality in men of African descent. Prostate Cancer. 2013;2013:12. doi: 10.1155/2013/560857.560857 - DOI - PMC - PubMed
    1. Mofolo N., Betshu O., Kenna O., et al. Knowledge of prostate cancer among males attending a urology clinic, a South African study. SpringerPlus. 2015;4, article 67 doi: 10.1186/s40064-015-0824-y. - DOI - PMC - PubMed
    1. Jemal A., Bray F., Forman D., et al. Cancer burden in Africa and opportunities for prevention. Cancer. 2012;118(18):4372–4384. doi: 10.1002/cncr.27410. - DOI - PubMed

LinkOut - more resources